Drug Profile
Research programme: epithelial stem cell therapies - EpiStem
Alternative Names: Epi 1461; Epi 2499; Epi 3423; Epi 5417; Epi 5539; Epi 5540Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator EpiStem
- Developer Epistem
- Class
- Mechanism of Action Stem cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; Gastrointestinal disorders; Wounds
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 04 Nov 2017 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in United Kingdom
- 04 Nov 2017 No recent reports of development identified for preclinical development in Wounds in United Kingdom